Upadacitinib: A Convenient and Effective Alternative Treatment for Spondyloarthritis

By HEOR Staff Writer

February 3, 2023

Treatment guidelines for adults with active non-radiographic axial spondyloarthritis recommend the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Tumor Necrosis Factor-alpha (TNF-alpha) inhibitors. If these first-line treatments don’t work or aren’t suitable, doctors may consider secukinumab or ixekizumab (IL-17 inhibitors). Clinical trials show that upadacitinib, an oral Janus Kinase (JAK) inhibitor, can reduce symptoms and improve the quality of life in Spondyloarthritis (SpA) patients. This effectiveness rivals that of biologics. Clinicians use the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score and/or Visual Analogue Scale (VAS) score to measure this. A cost comparison shows that upadacitinib costs about the same and provides similar health benefits as secukinumab and ixekizumab.

The update suggests considering upadacitinib as an alternative to the National Institute for Health and Care Excellence (NICE) recommended Interleukin (IL)-17 inhibitors. This is especially important if conventional therapy doesn’t control the condition well enough or if TNF-alpha inhibitors aren’t suitable or effective.

Clinical and patient experts highlighted the convenience of upadacitinib over IL-17 inhibitors owing to its oral administration.

Reference url

Recent Posts

Advancing Supply Chain Resilience in Europe’s Off-Patent Medicines Sector

By HEOR Staff Writer

April 28, 2026

In an interview with Adrian van den Hoven, Director General of Medicines for Europe, meaningful progress made in 2025 is highlighted, including the political agreement on the new EU ph...
Advancing Subcutaneous Diuretic Therapy for Heart Failure Management

By João L. Carapinha

Here we to examine how subcutaneous diuretic therapy is poised to transform the management of heart failure edema. SQ Innovation announced on April 28, 2026, that its Lasix® ONYU subcutaneous furosemide drug-device combination has achieved CE Marking under the EU Medical Device Regulation and has...
TikTok Opioid Overdose Forecasting: Leveraging Social Media Data for Enhanced Predictive Insights

By João L. Carapinha

TikTok Opioid Overdose Forecasting is gaining attention as a powerful new approach to public health surveillance. A new study shows that comments on opioid-related TikTok videos can significantly improve predictions of synthetic opioid deaths, reducing forecasting errors by up to 37% compared wit...